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Abstract
This work builds a prediction model for multi-omics breast cancer Nottingham Prognostics Index (NPI) classes. Rapid development in next-generation sequencing led
to the ability to measure different biological indicators called multi-omics data. The
availability of multi-omics data sparked the challenge of integrating and analyzing
these various biological measures to understand the progression of the diseases. Highdimensional embedding techniques are used to present the features in the lower dimension, that is a 2-dimensional map. This thesis presents a supervised learning
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build a diagnosis system for breast cancer NPI based on multi-omics data; (ii) find
gene biomarkers for each NPI class; (iii) build a novel prediction model based on
t-distributed stochastic neighbor embedding (t-SNE) and residual neural network
(ResNet) to integrate multi-omics data in the classification mechanism.
The dataset consists of three omics: gene expression, CNA and mRNA. We evaluated four models combining two embedding techniques, t-SNE and SOM, with two
different deep learning models, VGG and ResNet. The result showed that t-SNE
combined with ResNet in the concatenated approach outperformed the other methods with an accuracy of 98.48%. The set of genes extracted from the three omics can
serve as potential NPI associative biomarkers. The findings in the literature confirm
the associations between some of these genes and breast cancer prognosis and survival.
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Chapter 1
Introduction

1.1

Introduction to Molecular Biology

Molecular biology is a branch of biology that studies biological activity based on
molecules. It uses biochemical experiments to study the structure, function, processing, regulation, evolution and interaction of biomolecules, so as to gain insight into
the inner principles of life from cell build, cell growth to cell apoptosis. Proteins perform a variety of functions in living cells, and genes contain the information needed
to make more proteins.
Deoxyribonucleic acid (DNA) is reference of proteins, which are the functional
molecules in cells. DNA consists of four nucleotides (adenine, cytosine, guanine,
thymine), which are covalently linked to the polynucleotide chain (DNA chain) with
the sugar-phosphate backbone from which the bases extend. A DNA molecule is
composed of two antiparallel DNA strands, which are connected by hydrogen bonds
between base pairs, forming a twisted double helix as shown in Figure 1.1.1.
DNA transcribes into messenger ribonucleic acid (mRNA) that translates into
protein. mRNA is a single-stranded molecule of RNA that corresponds to the genetic
sequence of a gene, a ribosome reads mRNA in the synthesizing process into a protein.
1
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Fig. 1.1.1: DNA and its building blocks [5].

Fig. 1.1.2: Central dogma of molecular biology

2
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protein is the base of the body’s day-to-day activities including biological functions
and building blocks. The whole process of transcription and translation, which is
seen in Figure 1.1.2, is known as the central dogma of molecular biology [21].

1.2

Cancer

Cancer is defined as misbehaving cells in the tissue, a group of diseases that causes
abnormal growth of the cells in the blood or an organ. These uncontrollably dividing
cells have the ability to infiltrate and destroy normal body tissue. The tumor cells
take up 100 times glucose from the blood compared with normal adult cells and 85%
for producing lactate and 10% for synthesizing the proteins, nucleic acids, and lipids
required for tumor growth, only 5% for ATP by oxidative phosphorylation as shown
in Figure 1.2.1. As such, tumor cells have the selective advantage to spread into other
tissues.
Traditionally, cancers are categorised to carcinoma and sarcomas according to the
origin, the phenotype of the cancer cell. Breast cancer belongs to carcinoma cancers.

1.2.1

Breast Cancer

Breast cancer is a cancer that starts from the breast. In 2012, a merging study
by Curtis et al. clustered breast cancer into ten distinct subtypes based on the
patients’ molecular characteristics. Since then, these subtypes became the “new map”
of the clinical diagnosis of breast cancer [22]. Based on that study, breast cancer
molecular subtypes are heterogeneous diseases with diverse pathogens and clinical
features, where each subtype on its own exhibits a particular clinical behavior [19].
As such, different subtypes may lead to specific disease outcomes including prognosis,
treatment, and survival [41].
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Fig. 1.2.1: Metabolism of tumor cell [5].
Clinically, prognostic factors are used as an clinical guidance, including the evaluation of the need for further treatment for breast cancer patients, including adjuvant
systemic therapy, after local surgery. Three of them are most commonly used including tumor size, node status and. In addition, researchers are constantly discovering
whether there are new prognostic indicators, among which the Nottingham Prognostic Index (NPI) is used as a key indicator for the prognosis of the carcinoma breast
cancers. NPI is a statistical model designed by combining the most common prognostic factors. However, to date, there is no bioinformatics methods to detect potential
functional genes in breast cancer based on the NPI class.

1.3

Multi-Omics data

Human cell is a complex system that consists of small molecules (omics) which work
together to perform daily tasks. Due to the advances in next-generation sequencing
(NGS), the measurements of omics become affordably available which brings the challenge of how to integrate these measurements. These measurements come in different
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types including quantification, changes, events, images, text, and other genomicrelated data. The purpose of multi-omics integration analysis is to understand how
the cell molecules communicate with each other and the surrounding environment.
Omics are categorized based on their roles in the body into genomics, epigenomics,
proteomics, foodomics, transcriptomics, and metabolomics, among others [7].

1.4

Machine Learning

Machine learning is the field in computer algorithms that builds learning rules based
on experience from existing data. Machine learning is the part of artificial intelligence that concerns of how to deal with data to extract knowledge that can be used
in future decisions. Learning rules can be interfered by applying statistical, logical,
and mathematical learning methods on the data. The samples data that are used to
build the learning model is known as the training dataset, while the samples data that
are used to test the performance of the learning model is called the testing dataset.
Machine learning is applied in variety of fields within and outside of computer science including but not restricted to cyber-security, speech recognition, traffic system,
object recognition, computer vision, industrial engineering, health informatics, and
bioinformatics. This thesis is an application of applying machine learning algorithm
in bioinformatics field.
Machine learning methods are categorized into three techniques based on whether
they are labeled or not. These categorized are supervised learning, unsupervised
learning, and semi-supervised learning.

1.4.1

Supervised Learning

The samples data can be already known (labeled) before applying the learning methods to derived the learning rules. This is known as a supervised learning where the
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machine will improve the learning experience by looking at the samples of each label
(class) and inferring the rules (borders) for that class. Then the learning rules can
be used to map new non-labeled data into a class. The performance of predicting
the class in the supervised learning techniques can be evaluated using a set of performance metrics including accuracy, sensitivity, specificity, area under the cover (AUC),
Recall, Precision, and F-Score. These metrics can be derived from the confusion matrix. The confusion matrix consists of intuitive metrics to find the correctness of the
prediction model based on two dimensions (“Actual” and “Predicted”) for each class.
the classes can be defined as the (”Positive” and ”Negative”) classes. if the training sample predicted class matches it’s actual class, we denoted as true, otherwise,
it is denoted as false. The following equations show how to calculate some of the
performance metrics:

Accuracy =

(T Pi + T Ni )
(T Pi + F Pi + F Ni + T Ni )

(1.1)

T Pi
(T Pi + F Pi )

(1.2)

P recision =

Recall =

F 1 − score = 2 ×

T Pi
(T Pi + F Ni )

(1.3)

(P recision × Recall)
(P recision + Recall)

(1.4)

Where:
P stand for a Positive sample which is in class i;
N stands for a Negative sample which does not belong to class i;
T for True, and F for False.
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Naive Baysian [11], support vector machine (SVM) [13], k-nearest Neighbours
(k-NN) [30], and random forest [15] algorithms are examples of standard supervised
machine learning methods.

Random Forest classifier [57] is one of the state-of-the-art ensemble learning
methods, based on Breiman’s bagging idea [14]. It contains a bunch of classification
trees or regression trees according to the trait of the predictors, splitting and pruning
at each tree node for satisfying the conditions by the correlations between a specific
predictor and the label class or not. Equation 1.5 shows the typical splitting criterion
- Mean Squared Residual.
n

1X
Q=
(yi − y)
n i=1

1.4.2

(1.5)

Unsupervised Learning

Sometimes the samples data are not labeled, the learning method will try to find
patterns among the samples and group (cluster) the samples based on these patterns.
The clustering process groups the samples in same class if they are similar to each
other. The similarity can be measured using different distance algorithm, where the
sample of lower distance are similar. There are so many distance methods, the most
popular are Euclidean [37], Mahalanobis [49], and Manhattan distance [45].
Clustering is the techniques of grouping the samples based on the similarity among
them. Clustering has different models including centroid technique such as k-means
[48], Connectivity models such as hierarchy clustering [43], and distribution models
such as expectation-maximization algorithm [24]. The clustering method can be defines as a multi-objective optimization method, where the algorithm tries to minimize
the distance within the cluster samples, and maximize the distance between clusters
during the grouping process. These objectives can be evaluated using validity indices that contains many techniques, the most popular are Dunn’s Index [26], Davies
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Bouldin Index [23], C Index [42], and Silhouette Index [62].

1.4.3

Semi-supervised Learning

Semi-supervised learning falls between the supervised and unsupervised learning. It is
the part of machine learning that combines a small amount of labeled data with a large
amount of unlabeled data during training. Labeling samples process is expensive cost
that required human intervention in most of the cases, thus, minimizing the amount
of label data will decrease the cost. The Heuristic model is the oldest approach for
labeling data, which is also called self-labeling approach [63]. Generative models
are statistical approaches that utilizes the distribution of labeled data to cluster the
unlabeled data [61]. Laplacian regularization is another example of non-supervised
models that represent the data using graph-Laplacian by creating a node that link
each labeled and unlabeled example, then applies k-NN classifier to predict the label
[69].

1.4.4

Deep Learning

Deep learning is the part of machine learning that expand the neural networks by
adding more layers and more neurons to maximize the learning extracted features.
Neural network (NN) or artificial neural network is a series of circuits (nodes) that
tries to imitate the human brain function by finding the relationships between the
input and the output based on the learning features of the input [39]. ANN consists of
input, hidden, and output layer as seen in Figure 1.4.1. Each node has an activation
functions; that mimic the biological neurons in human body. Activation functions
including sigmoid [68] that is represented in Figure 1.4.2, rectified linear unit (ReLU)
[31] that is represented in Figure 1.4.3, and softmax [33] that is calculated based on
the probability of the sample to be in a specific output class as seen in Equation 1.6.
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Fig. 1.4.2: Sigmoid activation function.
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Fig. 1.4.3: ReLU activation function.

exp(xi )
Sof tmax(xi ) = P
j exp(xj )

1.4.5

(1.6)

Convolutional Neural Network

Convolutional Neural Network (CNN) is a class of neural network that uses kernel
function to extract the spatial attributes from the input. The kernel functions known
as convolution layer or feature maps, that was initially known as layer and the whole
CNN was known as space invariant artificial neural networks (SIANN) [71]. The
convolutional layer is depicted in Figure 1.4.4 that explains how feature maps can
extract spatial discriminative features. The CNN is usually applied in the imagery
data due to it is ability to extract spatial discriminative features. In 2012, krizhevsky
et al. proposed a very deep version of CNN that has more than hundred neurons to
classify images. The model revolutionized artificial intelligence image based study by
empowering the model using GPUs to extract the spatial features [46].
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input image
output feature maps

or input feature map

Fig. 1.4.4: Convolution layer.

1.4.6

Residual Neural Network

He et al. added a residual learning block to the ANN to over come the difficulty in
training of networks that are substantially deeper than those used previously. The
model replaces the unreferenced learning by explicitly reformulating the layers as
learning residual functions with reference to the layer inputs as shown in Equation
1.7. The results provide comprehensive empirical evidence showing that ResNets are
easier to optimize, and outperform normal ANNs from considerably increased depth
perspective [36]. Figure 1.4.5 illustrates the ResNet block diagram to show how to
use the prevouis learning as a referernce in the deepr added hidden layers.
Y = F (X, {Wi }) + X

Where:
X is the input vector;
Y is the output vector;
F (X, {Wi }) represents the residual mapping to be learned.

(1.7)
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⊕
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Fig. 1.4.5: ResNet block diagram.

1.4.7

VGG

VGG is introduced by Simonyan et al. in ”Very Deep Convolutional Networks for
Large- Scale Image Recognition” [30]. It is a classical convolutional neural network
architecture, comprised of many similar blocks of two Conv-layers with Relu activation function and a max pooling layer for feature selection to detect the similarity or
difference of the pixels and spacial characteristics of the training inputs for classification with softmax function in most case. Its structure is as illustrated in Figure.
1.4.6.

Fig. 1.4.6: Basic VGG model.
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Dimensionality Reduction

Dimesionality reduction is the process of transforming the data from a high-dimensional
space into a low-dimensional space, where the low-dimensional representation retains
some meaningful properties of the original data including separation between samples, ideally close to its intrinsic dimension. The well-known methods of dimesionality reduction including principle component analysis (PCA) [55], linear discriminant
analysis (LDA) [29], and neural network types. In this thesis we used two neural networks methods which are t-Distributed Stochastic Neighbor Embedding (t-SNE) [66]
as part of the proposed method, and Self-Organizing Map (SOM) [44] for comparison.

1.5.1

Self-Organizing Map

Self-Organizing Map (SOM) reduces the dimensionality of the dataset by clustering
the samples’ vectors based on the similarity among their features. The unsupervised
uses the Euclidean distance to find the similarity between the vectors of features.
SOM incorporates somNet [20] that updates the networks neuron values based on
the Euclidean distance between the samples gene gij and the feature center cj as the
following equation:

dj =

q
Σni=1 (gij − cij )

(1.8)

Where:
n is the number of samples.j is the current feature in the feature vector
v = {v1 , v2 , . . . vj . . . vm }, m is the number of features.
In somNet, The neurons with less dj are declared as the winner of the competition
to be the representative of the data. In other words, this neuron is known as the best
matching unit (BMU).
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t-Distributed Stochastic Neighbor Embedding

Hinton et al. presented stochastic neighbor embedding (SNE) as a dimensionality
reduction technique. SNE finds the similarity between samples in higher dimensional
space into a lower-dimensional space using local Gaussian distribution in both ends
[38]. The Gaussian distribution in the embedded lower-dimensional space does not
give enough weights for the distant samples from the center point, which leads to less
separation between samples in the embedded space. Therefore, t-distribution SNE
was proposed to solve such a ”crowding problem” by applying the t-distribution as
shown in Equation 1.10, which is used in the low-dimensional space instead of the
local Gaussian distribution, while the higher dimensional space still uses the local
Gaussian distribution expressed in Equations 1.9 [66]. The gradient descent with a
momentum helps to find a global minimum in a relatively lower cost as shown in
Equation 1.11.

pij =

pi|j + pj|i
, pij ̸= pji f or ∀ i, j
2n

(1.9)

Where:
pij is the joint probability in the high dimensional space;
pi|j and pj|i are the conditional probability in the high dimensional space.
In the high dimensional space,
(1 + ||yi − yj ||2 )−1
qij = P
̸ qji f or ∀ i, j
2 −1 , qij =
k̸=l (1 + ||yk − yl || )
Where:
qij is the joint probability in the low-dimensional space.

(1.10)
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=4
(pij − qij )(1 + ||yk − yl ||2 )−1 (yi − yj )
δyi
j
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(1.11)

Where:
δC
δyi

1.6

is the gradient descent.

Problem Statement

This thesis is addressing the following deep-learning and breast cancer challenges and
issues:

• Patients with breast cancer bad prognosis have less survival rate than medium
and good prognosis.
• The survival of NPI > 3.4 drastically drops from more than 84% to less than
40% according to 15-year survival studies [3].
• Finding multi-omics biomarkers that play roles in NPI advancement.
• Build a multi-source prediction model based on the multi-omics data to predict
the outcome of NPI.

1.7

Research Objectives

The following are the main objectives of this research:

• Find potential biomarkers for breast cancer NPI levels of after surgery advancement.
• Build a Multi-input deep learning method to integrate multi-omics data.
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• Create a hybrid feature selection method to (greedily) find the best sub-set of
multi-omics features.
• integrate Multi-omics data including gene expression, copy number alteration
(CNA), and mRNA data that to build the prediction model.
• build a multi-input deep learning that is based on ResNet, and optimize the
performance of model.

1.7.1

Contributions

The List of contributions in this work contains the following:
• A prognosis deep learning prediction model for breast cancer NPI scores.
• The novel prediction model is based on t-SNE feature mapping to create a
2-dimensional images and ResNET neural network.
• The prediction model integrates multi-omics data and can be used for any multisource data integration. Where the integrated discriminative features can fairly
extracted from all sourced with no directive or bais toward a certain source of
data.
• Multi-class prediction deep learning approach.
• A set of potential gene biomarkers related to each level of NPI scores. This
gene can be careful analyzed by literature and wet-lab experiments then used
as a prognostic biomarkers for breast cancer.

Chapter 2
Prediction of Breast Cancer NPI
for Five-year Survival

2.1

Introduction

Breast cancer (BC) is the most common cancer and a leading cancer death in women
worldwide [can]. BC is a heterogeneous disease that consists a several subtypes which
have been identified at the clinical, molecular, genomic and histological levels. Early
detection and intervention is proven to be effective in increasing the survival rates
and improves the prognosis [40]. Nottingham Prognosis Index (NPI) is an index to
determine prognosis following surgency for BC [35]. Various studies have validated the
prognostic discrimination [25, 32, 65], and NPI is used widely in clinical practice. The
NPI combines nodal status, tumour size and histological grade in a simple formula:
N P I = [0.2 × S] + N + G

Where:
S is the size of the index lesion in centimeters;
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(2.1)
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Level

Score

Survival-rate

I

>= 2.0 to <= 2.4

93%

II

> 2.4 to <= 3.4

85%

III

> 3.4 to <= 5.4

70%

IV

> 5.4

50%
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Table 2.1.1: NPI levels and their 5-years survival rate.
N is the node status: 0 nodes = 1, 1-3 nodes = 2, >3 nodes =3;
G is the grade of tumor: Grade I = 1, Grade II = 2, Grade III = 3 [59].
Machine learning models were used in breast cancer prognosis prediction [8, 12,
28, 73]. Boeri et al. investigated the standard machine learning classifiers to predict
three outcomes that are loco-regional cancer recurrence, systematic cancer recurrence,
and death from the disease with in 32 months. The results show that artificial neural
network (ANN) and support vector machine (SVM) outperformed some other standard classifiers with accuracy higher than 95% for the three classes [12]. Ferroni et
al. applied a machine learning model based on demographic, clinical and biochemical data to predict the survival of breast cancer. The model incorporates multiple
kernel learning (MKL) based on support vector machines (SVM) combined with random optimization (RO) models to extract the discriminative features and build the
classification model. The results shows that NPI is one of the prognosis indicators
that strongly influence the survival [28]. In this thesis, we are extending our previous
work [73] by replacing the clinical data to be mRNA. Second, we added the number
of NPI class to be 5 instead of 2 and the samples to be 1885 instead of 166. The most
important thing is that we derived more insights by comparing the multiple models.
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Materials and Preprocessings
Materials

In this study, we considered the well-known METABRIC dataset [22] that is publically
available on cbioportal.org portal. 1,885 samples were selected out of 2,433 samples
that belong to female patients who have NPI status updated in the dataset. They
were categorized into the the original study [35] NPI classes that are shown in Table
2.1.1.
For the selected samples, we extracted a three omics from the METABRIC dataset
which are gene expression, mRNA, CNA. The numbers of features for all omics are
listed in Table 2.2.1.
Dataset Name

Number of Genes

Number of Samples

Gene Expression

16567

1885

mRNA

16567

1885

CNA

16401

1885

Table 2.2.1: Datasets after sample and gene mapping.

2.2.2

Preprocessings

Genome-wide data has the characteristics of high-dimensionality. Besides, it also
suffers from data incompleteness due to sequencing technology or loss of biological
information.
In our study, to keep the reliability of the data, we drop the patients with missing
values in three omics data sets. As a result, the dataset ended up with 1,885 samples.
Also, as of the features, we renamed the overlapped ones and kept them.
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Methods

The methods section start with hybrid feature selection, then applying data embedding, and the prediction model.

2.3.1

Feature Selection

A hybrid feature selection that consists of ranker and wrapper feature selection methods to select the best possible subset of features for each omic data set. The ranker
Chi-Square was applied on the three omics data sets, to select 1,000 top genes, followed by the wrapper that works as the following:
• Chi-Square[54], is a statistical ranker-based feature selection method to select
top N features that are sensitive to the label NPI. Equation 2.2, 2.3, 2.4 show
how Chi-Square works, by which we decided to select the top 1,000 features
from 16,041 features in the gene expression data set. For a specific gene, it
first sums up the expression level according to the label as the observed values.
Then it counts the number of the samples belonging to each class, divided by
the total number of the samples, which is the class probability. After that, the
class probabilities are multiplied by the sum of the expression level of that gene,
and we call the result as the expected value. Finally, the square of the difference
between the observed value and the expected value is divided by the expected
value. The sum of the obtained results is the chi value of the individual gene.
In our experiment, we picked up the top 1,000 genes from gene expression data
set, CNA and mRNA, respectively.

Ojc =

n
X

xijc

(2.2)

i=i
N

Ejc =

nc X
×
Xij
N
i=1

(2.3)
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χ2(Xj , Y ) =

k
X
(Ojc − Ejc )2

Ejc

c=1
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(2.4)

Where:
nc is the number of samples belonging to class c;
i is the ith sample patient, i ∈ {1, 2, ..., N };
j is the j th feature gene, j ∈ {1, 2, ..., m};
c is the cth NPI class, c ∈ {1, 2, ..., k};
N is the total number of samples;
• mRMR is a wrapper feature selection algorithm that finds a compact subset
of superior genes with the characteristics of maximal relevance to the NPI class,
that is max D(S,c) and minimal redundancy in the feature subset, that is min
R(S), according to the maximal statistical dependency criterion based on mutual information, described in Equation 2.5, 2.6. As a result, top 30 genes are
selected from 1000 genes for each omics in the concatenation approach 30 genes
for gene expression only in the merging way.

maxD(S, c), D =

1 X
I(xi , c)
|S| x ∈S

(2.5)

i

minR(S), R =

1 X
I(xi , xj )
|S|2 x ,x ∈S
i

(2.6)

j

Where:
S is the subset of superior genes;
c is the NPI class;
xi , xj are the sample vectors of the ith and j th genes with the shape of 1
× N (N is the number of samples).
In this work, mRMR incorporates random forest classifier with forward search
feature selection to obtain the best possible subset of features that represent
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Fig. 2.3.1: Boxplot of target genes in gene expression data set.
each omic data set. As a result, there are 17, 22 and 22 genes for gene expression, CNA and mRNA as shown in Table 2.3.1. Figure 2.3.1 reflects the
expression levels of the target genes, in which it is clear that the expression level
of TCN1 has a substantial interval of variation. The larger the variation, the
more suspicious the gene will be that plays its role in breast cancer as a marker
gene. Actually, LYZ Chong et al. reported that high level of TCN1 in human
serum is associated with phyllodes of breast tumours [18].

2.3.2

Dimensionality Reduction

Dimensionality reduction is a technique used to embed high-dimensional data points
into a lower-dimensional space to seek a pattern that represents the original feature
map [66]. In our study, we projected the genes from 1885 dimensions to 2 dimensions
using t-SNE and SOM. The 2-D map is a gene similarity network (GSN). It helps to
detect their biological insight.
• t-SNE is a good choice to keep both of the global and the local information
among the genes well. It first calculates the similarity of the genes by Euclidean
distance in the original 1885-dimensional space and projects them into a 2-D feature map by calculating the pairwise similarity in the 2-D space using t-student
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17 Target Genes in Gene Expression Dataset.
NO

Gene

NO

Gene

NO

Gene

NO

Gene

01

CDCA5

06

TUBA3C

11

PIGV

16

RRM2

02

IL17RB

07

BX648950

12

TCN1

17

QSOX1

03

MUC2

08

NXPH4

13

BOLA2B

04

ZNF311

09

UCP1

14

KIF16B

05

NOD2

10

SLC25A13

15

RRP7A

22 Target Genes in mRNA Dataset.
NO

Gene

NO

Gene

NO

Gene

NO

Gene

01

CENPA

07

IGSF22

13

ZNF18

19

ABLIM2

02

SLC5A10

08

RRP7A

14

ORC6

20

SORBS2

03

CD3G

09

SLC35A2

15

TMEM191C 21

PDSS1

04

MACF1

10

CCDC74A

16

SEMA3B

22

GANC

05

SCNN1D

11

MRPS7

17

ZIC2

06

UGT2B7

12

COLGALT1 18

IQCH

22 Target Genes in CNA Dataset.
NO

Gene

NO

Gene

NO

Gene

NO

Gene

01

RAD21AS1

07

EIF3H

13

NOV

19

ENPP2

02

PXK

08

LINC01151 14

NDRG1

20

OTUD6B

03

MED30

09

LINC00536 15

CSMD3

21

MTBP

04

MIR3610

10

EXT1

16

MAL2

22

CENPH

05

LOXL2

11

EIF3E

17

DPEP1

06

RAD21

12

COLEC10

18

OXR1

Table 2.3.1: Target genes in three data sets.
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function. The pairwise similarity is the joint probability between a specific gene
and another gene excluding itself. To some extent genes with similar biological
functions or pathways will get close to each other, while biologically unrelated
genes will repel each other.
The left part of Figure 2.3.2 is the templates embedded for our model in the
concatenated way, so we call them concatenated tSNE GSN, and the first of
them is the merged tSNE GSN for our model in a merging way. For each
dataset, we set the epoch to 5000 and the learning rate to 0.01. Because the
marker genes of each dataset are different, the three templates also vary greatly.
If we take a closer look at the first template, we will see that NOD2 and CDCA5
are adjacent to each other, while .
• SOM is simple neuron network algorithm that allows us to investigate the intrinsic relationships among samples of a dataset. As such, the data points with
smallest weights to the winning neuron will be grouped in the same cluster,
forming the gene similarity network (GSN) as a result, then colored by the
transformed values of each gene from the three omics datasets in a merged
way or a concatenated way.

We call them merged SOM GSN or concate-

nated SOM GSN. The left part of Figure 2.3.3 shows the three templates for
gene expression, CNA and mRNA embedded by SOM.

Ideally, the GSN reveals the closeness of the most informative genes in terms of
biological pathways or functionality. Therefore, the ”colored template” shows a
representation of each NPI class based on the relationship among their marker
genes. Fig. 2.3.2 and Fig. 2.3.3 show the tSNE GSN and SOM GSN template
creating and coloring in a concatenated way, while the marker genes in the
tSNE GSN map has an even distribution, which leads to a capacity of holding
more marker genes inside than SOM GSN map.
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Fig. 2.3.2: Templates of three omics datasets embedded by t-SNE (concatenated).
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Fig. 2.3.3: templates of three omics datasets embedded by SOM (concatenated).
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Fig. 2.3.4: One block in residual neural network.

2.3.3

Deep Learning

• ResNet In ResNet, the residual learning is applied to every few stacked layers,
that is called a block shown in Figure 2.3.4. In the output layer of each block,
there is an identity mapping by shortcuts, and the output y can be expressed
by the product dot of weight vector and input x, then added to the identity
mapping x. For each GSN map, it is first normalized before learned by the
Convolutional layer with Swish activation function, to transform each neuron
by adding a weight without pooling layer or droup out for shrinking, so that it
could train GSN maps in a much deeper way than other CNN structures such
as VGG.
• VGG is a classical CNN model. It first extracts the feature inside the GSN maps
using a 3 × 3 convolutional layer with Relu activation function to transform the
inputs by adding a weight vector to the gene vector. The max pooling layer is
then added to further shrinks the feature map by extract the max value within
a 2 × 2 stride. In predicting process, softmax is a common function to output a
probability vector for NPI classes. Usually, the class with the max probability is
the predicted result. Because of continuous shrinking by max pooling layer and
drop out layer, VGG can make a classification for images in a limited layers.
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Proposed Model and its Complementary Models

Concatenated ResNet Model is our proposed model that applies three ResNets
to the three group of GSN maps derived from expression data, CNA and mRNA at
the same time to ensure that for each group, the input sample ID is the same. For a
single ResNet architecture, it is assembled in such a way:
• In the first step, GE GSN maps are fed into a batch nomalization(BN) layer
with the batch size of 64, then a 3 × 3 convolutional layer extracts the features
using ’Swish’ activation function to transform the values of genes by adding the
weights and summing up the dot production of the feature vector and weight
vector.
• Similarly, it repeats BN, Conv-layer with ’Swish’ transformation once again.
• Then, the normalized transformed feature vector is compared with the identity
of the input and the weights are adjusted according to the residual using ’Swish’
function.
• The first step repeats once again, and then the residual is calculated as described
in the third step. And this repeats four times.
• The first and second steps reiterates.
• The combination of fifth and sixth steps repeats 3 times.
• The first step again is applied to the derived feature vector.
• Once again, the third step repeats.
• Then the dropout layer is added followed by a flatten layer to the normalized
batch.

At the end, these three ResNet concatenate for global pooling, followed a Dense
layer with the ’Softmax’ function for classification to produce a probability vector con-
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Fig. 2.3.5: Resnet modelling (concatenated)
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taining five probabilities for each NPI class. And the class with the max probability
is the NPI class that the sample patient belongs to.
According to the different embedding method, it is further catagolized as Concatenated tSNE ResNet and Concatenated SOM ResNet.

Concatenated VGG Model is a complementary model as shown in Figure 2.3.6.
It applies three VGG modules to GE GSN maps, CNA GSN maps and mRNA GSN
maps, respectively at the same time. For a single VGG module, it is presented by
the following steps:
• In the first step, a batch of 32 GSN maps are fed into a 32 window 3 × 3
convolutional layer with ’Relu’ activation function to transform the inputs, then
followed by a BN layer for batch normalization.
• The first step repeats again.
• A maxing pooling layer with a 2 × 2 stride is applied before a dropout layer
with a rate of 0.2.
• It iterates from step 1 to step 3 by adjusting the number of window of Convlayer to be 64, 128 in the second and third iteration. The same to the dropout
rate, it is 0.3 and 0.4 for the second and third repeat.
• The last layer in a single VGG layer is a flatten layer.
At the end, these three VGG modules concatenate for global pooling, followed by
the same classification block as that in the Concatenated ResNet Model. According
to the different embedding method, it has two sub-models: Concatenated tSNE VGG
and Concatenated SOM VGG.

Merged ResNet Model is the second complementary model as drawn in the right
part of Figure 2.3.7. It applies the same single ResNet module to train the Merged GSN
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Fig. 2.3.6: VGG modelling (concatenated)
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Fig. 2.3.7: Modelling in merging approach. A) Feature selection using ChiSquare, mRMR and Random Forest. B) SOM and t-SNE embedding to draw
two 2D templates of the selected 22 genes. The left template is done by SOM
and the right template is drawn by t-SNE. Then the templates are colored
by combining the three omic data sets. C) The 33-layer VGG model. D) The
112-layer ResNet model.
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maps with the same parameters and then continues with the fully connect layer with
”Softmax” function, without pooling layers.
We call Merged ResNet Model that uses the ResNet GSN maps as the inpus as
Merged tSNE ResNet. While that uses SOM GSN maps is named as Merged SOM ResNet.

Merged VGG Model is the third complementary model in the left part of Figure 2.3.7. It has the same VGG module described in Concatenated VGG Model.
However, before fully connect layer with softmax function, there is no global pooling
for feature extraction.
Merged VGG Model also contains two sub models. In Merged tSNE VGG, Merged GSN
maps are the inputs, while in Merged SOM VGG, Merged GSN maps are the inputs.

2.4
2.4.1

Experiments and Results
Experiments

Our experiment aims to find a fit model that is best for finding the potential marker
genes in breast cancer that plays key roles in NPI classification. The system configuration information is listed in Appendix A.
We trained and predicted the GSN maps using eight models that are explained
in the former chapter. The optimizer is stochastic gradient descent (SGD) with a
momentum of 0.9 and a learning rate of 0.01. The activation function is softmax in
Equation 1.6. For evaluating the performance, we tried three metrics, ’Accuracy’,
’AUC’ and ’Loss’.
T

eX wj
P (y = j|X) = K X T w
j
Σk=1 e

(2.7)
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Where:
X is the sample vector;
wj is the weight vector of j th feature;
K is the number of features, here it is 22;
Table 2.4.1: Performance comparison among classifiers and embedding methods (merged).
Model

Accuracy Validation Loss
Accuracy

Validation AUC Validation
Loss
AUC

Merged-SOMVGG

0.8972

0.87858

0.2539 0.21189

0.9913 0.97

Merged-SOMResNet

0.9702

0.8653

0.1062 0.2647

0.9985 0.9649

Merged-tSNEVGG

0.9384

0.8265

0.31

0.2210

0.9845 0.8979

Merged-tSNEResNet

0.9609

0.8371

0.1471 0.2797

0.9958 0.9179

Table 2.4.2: Performance comparison among classifiers and embedding methods (concatenated).
Model

Accuracy Validation Loss
Accuracy

Validation AUC Validation
Loss
AUC

ConcatenatedSOM-VGG

0.9375

0.75

0.2044 1.043

0.9956 0.8662

ConcatenatedSOM-ResNet

0.9572

0.75

0.1801 0.82

0.9990 0.9452

ConcatenatedtSNE-VGG

0.9773

0.8

0.0972 0.7122

0.9991 0.9500

ConcatenatedtSNE-ResNet

0.9848

0.8

0.0546 0.5909

0.9999 0.9625
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Fig. 2.4.1: Accuracy plots of 8 models.

2.4.2

Results

Table 2.4.2 and 2.4.1 show the performance of our proposed model and other similar
models for comparison. Among eight different models, the models in the concatenated
way have higher accuracy and AUC, but lower loss in the training process. Conversely,
predicting performance in the merged way outperforms that in the concatenated
approach.
Figure 2.4.1, 2.4.2 and 2.4.3 illustrate the accuracy, AUC and loss in the training
process with the epoch of 100. By analysing the experimental data, we discovered
that:
• Concatenated ResNet models could do the feature selection and recognization
faster only within 30 epochs than other models that contained 100 epochs. Concatenated tSNE ResNet and Concatenated SOM ResNet got their final best
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Fig. 2.4.2: AUC plots of 8 models.

Fig. 2.4.3: Loss plots of 8 models.
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performance at the 30th epoch with the accuracy of 98.48% and 93.73%, AUC
of 99.99% and 99.56%, loss of 0.0546 and 0.2044, respectively.
• It is obvious that the merged models and Concatenated VGG models gradually increased their accuracy to the end of the 100th epoch, in which Concatenated tSNE VGG and Concatenated SOM VGG have a more fluctuating accuracy tendency than others. In the beginning, they both have the lowest accuracy, then Concatenated SOM VGG outperformed Concatenated tSNE VGG
until they were at the 60th epoch, the later model caught up with the former
to reach the same level, and then Concatenated tSNE VGG surpassed Concatenated SOM VGG, with the final accuracy of 97.73% and 93.75%, AUC
of 99.99% and 99.56%, loss of 0.0546 and 0.2044, respectively. The same phenomenon occurred in the other three groups of models, Merged tSNE VGG compared with Merged SOM VGG, Merged SOM ResNet compared with Merged tSNE ResNet, and Concatenated SOM ResNet compared with Concatenated tSNE ResNet, indicating that there is a fixed tendency in the performance
metrics for t-SNE and SOM embedding with the same prerequisites.
• By evaluating Concatenated tSNE ResNet with Concatenated tSNE VGG, we
find that Concatenated tSNE ResNet behaved better in the whole training process. In the end of the training process, Concatenated tSNE ResNet got an accuracy of 98.48%, AUC of 99.99% and loss of 0.0546, outperforming that of Concatenated tSNE VGG, 97.73%, 99.91% and 0.0972%. It also happened to other
pairwise models of Concatenated SOM VGG vs Concatenated SOM ResNet,
Merged tSNE VGG vs Merged tSNE ResNet, as well as Merged SOM VGG vs
Merged SOM ResNet. Therefore, we assessed that ResNet models have better
ability of extracting feature and classifying the input images by keeping other
variants unchanged.
• Concatenated tSNE VGG and Merged tSNE VGG have the same embedding
method and classification structure, while the concatenated one outperformed
the merged one from the very beginning. The three performance metrics( accu-
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racy, AUC and loss), are 97.73%, 99.91% and 0.0972 for Concatenated tSNE VGG
and 93.84%, 98.45% and 0.31 for Merged tSNE VGG. Moreover, given the same
embedding technique and deep learning model, the ones in the concatenated way
trained the GSN maps better than those in the merged approach. Thus, we inferred that the concatenated model is more effective that the merged one when
using the same embedding method and deep learning structure.

2.5

Discussion

Genes extracted from the gene expression omic dataset that play key roles in the development of breast cancer are CDCA5, IL17RB, MUC2, NOD2, and NXPH4. CDCA5
is a member of the cell division cycle-associated (CDCA) gene family. Specifically,
it controls sister-chromatid cohesion and separation during cell division. Phan et al.
screened the mRNA expression of the CDCA genes and found that the expression of
CDCA5, along with CDCA3 and CDCA8 was significantly high compared to the control sample. High expression of these genes in tumors dramatically reduced patient
survival, which has the potential for being a target for breast cancer therapies [56].
According to another study by Zhang et al., CDCA5 also has the potential to become a prognostic strategy because it has been found to be significantly up-regulated
in gastric cancer (GC) tissues. When CDCA5 was inhibited in gastric cancer cells,
it suppressed their proliferation, demonstrating how CDCA5 promotes GC tumor
progression [72].
IL17RB is a member of the IL17 gene family. IL17 genes encode for proinflammatory cytokines, which are produced from inflammatory diseases such as breast
cancer. One of the IL17 genes is IL17B, which binds to its receptor, IL17RB. The
IL17RB signalling pathway plays a key role in its progression, so targeting this pathway is a potential therapeutic pathway for breast cancer inhibition [6]. Alinejad et al.
demonstrated that the IL17RB signalling pathway triggers an increase in cell growth
through activation of NF-KB and Bcl-2 [6].
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MUC2 is a member of the Mucins family, which are glycoproteins expressed and
secreted as mucus by epithelial cells and their malignant counterparts [60]. MUC2 is
a protein that is highly expressed in mucin secreted breast cancers. MUC2 plays an
important role in mediating proliferation, apoptosis, and metastasis of breast cancer
[9].
NOD2 is an innate immune receptor that is associated with the onset and progression of triple negative breast cancer (TNBC). Overexpression of NOD2 is shown
to reduce cell proliferation. The pathways that link NOD1 and NOD2 signaling to
tumorigenesis have been studied by Velloso et al. and found that the up- and downregulation of inflammatory proteins can promote protein degradation systems and
modulate cell cycle and cell adhesion proteins [67].
NXPH4 is a mitochondria-related core gene that is involved with the progression
of breast cancer. Yan et al. have found that NXPH4 is up regulated in breast cancer,
which can be used as a potential biomarker for breast cancer prognosis and diagnosis
[70].
One of the genes found in the CNA omic dataset is MED30, which is a core subunit in a group of mediator complex subunits that are found to be mutated in various
malignancies in glioblastoma (GBM), a malignant form of glial cell cancer. MED30
was found to be overexpressed in GBM tissues and cell lines and was also found to be
induced by conditions present in tumor environments, such as hypoxia. MED30 contains hypoxia response elements (HREs) and a p53 binding site in its promoter region,
which has shown that MED30 promotes cell proliferation while reducing migration
capabilities in GBM cell lines. Its involvement in GBM pathogenesis has also revealed
that MED30 is sensitive to the chemodrug temozolomide suggesting a diagnostic and
therapeutic potential [64]. MED30 has also been reported to be overexpressed in
various breast cancer cell lines, along with MED1 and MED24 [34].
RAD21 is a gene that is believed to function in sister chromatid alignment and
in double-stranded break repair. Expression studies have revealed a 2-fold increased
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expression of RAD21 in human breast cancer cell lines compared to normal breast
tissue. Atienza et al. conducted experiments with RNA interference technology
and found that the proliferation of cells with RAD21-specific siRNA was reduced.
This suppression of the RAD21 gene also enhanced the cytotoxicity of etoposide and
bleomycin (two DNA-damaging chemotherapeutic agents), which revealed that by
the induction of DNA damage, RAD21 can be a novel target for developing cancer
therapeutics [10].
EIF3H is a gene that is involved in the pathway for the metabolism of proteins
[EIF] and it is involved in translation inhibition factor activity. Mahmood et al.
performed an siRNA screening in three breast cancer cell lines for candidate driver
genes that are overexpressed in breast tumors, which identified eight driver genes
that were amplified and critical for breast tumor cell proliferation, which included the
EIF3H gene, along with some other well-described oncogenic drivers ERBB2, GRB7,
RAD21, CHRAC1, and TANC2. Therefore, strategies for inhibiting the expression
of these genes are of potential value for the treatment of breast cancers [50].
Another potential gene biomarker in the CNA dataset EIF3E, which is related
to EIF3H, a translation factor associated with breast cancer occurrence. It has been
previously shown that EIF3E deficiency leads to an impaired DNA damage response
along with a marked decrease in DNA repair via homologous recombination. Mahmood et al. found that EIF3E-depleted cells synthesized lower amounts of PARP1
protein, and the mTORC1 signaling pathway is more activated. These PARP1 and
mTORC1 dysfunctions are linked to the induction of cellular senescence, which provides mechanistic insights into how EIF3E protects against breast cancer. Findings
suggest that these cancers may benefit from mTORC1 inhibitor drugs [52].
Another gene found in the CNA dataset is MAL2, which is a gene that has been
identified to determine the turnover of the antigen-loaded MHC−I complex and reduces antigen presentation on a tumor cell, which promotes immune evasion. Fang et
al. show how MAL2 accomplishes this by promoting the endocytosis of tumor antigens by directly interacting with the MHC−I complex and endosome-associated RAB
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proteins. It has been shown that the supressing of MAL2 has enhanced the cytotoxicity of tumor infiltrating CD8+ T cells and suppressed breast tumor growth, which
suggests that this gene can be a potential biomarker for breast cancer therapy[27].
Genes extracted from the mRNA dataset, which show great significance in the
development of breast cancer, are CENPA, MACF1, UGT2B7, SEMA3B. Centromere
protein -A, which is also known as CENPA, is a histone-like gene that is important
for the regulation of chromosome segregation that occurs during cell division. It is a
gene that is commercially available for prognostic assays for breast cancer. Rajput
et al. found through the measuring of the immunohistochemical (IHC) expression
of CENPA in tissues that breast cancer tissue had higher levels of IHC than normal
breast tissue. They found that higher IHC expression correlated to a shorter disease
free survival (DFS), making CENPA a potential prognostic biomarker [58].
Microtubule actin cross-linking factor 1, also known as MACF1, is a gene that
plays an essential role in various cellular processes, such as proliferation and embryo
development. It is also known to be a gene that is responsible for the development
of breast cancer. MACF1 also plays a role in cytoskeleton organization in cells,
which contributes to tumor progression, and abnormal expression of MACF1 initiates
proliferation, metastasis, and migration in breast cancer [51].
Uridine glucuronosyltransferase 2B7, also known as UGT2B7, is a gene that belongs to the UGT gene family, and it plays an essential role in the elimination of toxic
xenobiotics and endogenous compounds and is found in the microsome membrane
[UGT]. Li et al. studied the occurrence of cytotoxicity in breast cancer patients
undergoing chemotherapy along with the expression of the UGT2B7 gene. Their
results showed that breast cancer patients with the UGT2B7 gene had a lower occurrence of cardiotoxicity [47]. It has also been found by Mou et al. that a gene in the
UGT2B7 gene called RS745335 was associated with breast cancer patients receiving
chemotherapy, therefore making the RS745335 and UGT2B7 potential biomarkers for
breast cancer [53].
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Semaphorin 3B, also known as SEMA3B, is a gene that belongs to the semaphorin
family and is important in the process of growth cone guidance during neuronal
development [SEM]. Castro-Rivera et al. have studied how SEMA3B acts as a tumor
suppressor by inducing apoptosis. They found that another growth factor called
VEGF165 binds to neuropilin, which is also a receptor for SEMA3B, and it decreases
the proapoptotic effect that SEMA3B had since it will competitively bind to those
receptors. Therefore, it was concluded that VEGF165 was produced by tumor cells
and was used as a surviving factor, and SEMA3B has tumor-suppressing effects by
blocking this VEGF pathway [17]. In a related study by Castro-Rivera et al., it was
found that SEMA3B induces apoptosis by inactivating the Akt signaling pathway
through the Np-1 receptor [16].

Chapter 3
Conclusion and Future Work
In this chapter we present what we concluded from this project and suggest directions
for future work.

3.1

Conclusion

NPI, as a useful clinical indicator of breast cancer prognosis, shows its important
status in the medical research area. We have proposed a method that focuses on
identifying different NPI class using powerful manifold learning t-SNE for dimensionality reduction combined with deep learning methodologies on METABRIC breate
cancer dataset. This pipeline performs downstream analysis such as quality metrics
evaluation, dimensionality reduction, and classification. We have conducted extensive experiments to find the optimized parameters for dimensionality reduction and
classification by finding the suitable number of marker genes and the coloring method
of GSN template, and classifiers, respectively.
• Dimensionality reduction methods can be applied to project the high-dimensional
genes into a 2-D GSN map based on the sequencing value. t-SNE embedding
approach outperforms self-organization map (SOM) by improving the common
43
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”crowding problem” that enables to hold more neurons in the GSN map in an
even distribution, evident in our GSN maps embedded by t-SNE and SOM.
• ResNet is a better choice for GSN maps with subtle characteristics to be extracted, compared with VGG.
• Using multi-omics datasets shows our proposed method’s general accuracy and
turns out to be a promising approach for predicting the NPI class.
• RGB coloring helps to capture biological feature for the marker genes because it
integrates the three omics into the three elements R, G and B in the GSN maps
drawn in a merged way. In contrast, helix color system is another technique for
coloring the GSN maps that derived in the concatenated approach, because it
has only one element in RGB system.
• Performing biological analysis of the selected genes indicates biomarker genes
involved in different gene ontology terms.

Overall, we proposed a pipeline to highlight the performance of a combination of
dimensionality reduction techniques and deep learning methods to predicate NPI
class.

3.2

Future Work

This work can be further extended by:
• The spatial relationship in the GSN map reflects the biological pathway or function. Different dimensionality reduction techniques can map potential relationships among the target genes. Therefore, more techniques can bring us more
innovative biological insight. Apart from SOM and t-SNE, other approaches
such as Laplacian eigenmaps, LLE and IsoMap are good choices. As such, we
can get a more correct conclusion by comparison.
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• Gene expression, CNA and mRNA are three common sequencing data sets, but
other data sets, including CMA, contain different genetic information that can
be integrated into the deep learning model and contribute to feature selection
and classification. Therefore, applying the proposed methodology on multiinput data sets (more than three) to verify the prediction strength of the model.
Then, comparing the results with state-of-the-art methods for multi-input data
sets.
• 17 to 22 genes is a minimal group of breast cancer cell biopsy, lacking enough
biological information that perhaps contributes to NPI classification. Therefore,
more genes can be detected as potential marker genes in the GSN map for the
downstream analysis, combining different dimensionality reduction strategies
for selecting genes or employing feature selection methods.
• Colouring the GSN template using RGB is a common method but limited to
merging three omics datasets into three elements in the RGB system. Heatmap
colouring is an alternative. It takes the value of a single gene as the central
point and then gradually expands according to the distance to the center. It
can solve the problem of colouring the GSN map for a single data set. Besides,
it can reflect the geometrical information between the target genes.
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Appendices

Appendix A - System Configuration
NAME

VERSION

anaconda

2020.11

jupyter

6.1.4

keras

2.4.3

matplotlib

3.3.2

numpy

1.19.2

pandas

1.1.3

python

3.8.5

scikit-learn

0.23.2

simpsom

1.3.4

tensorflow

2.4.1

operationg system

Catalina

processor

2.6 GHz 6-Core Intel Core i7

memory

16 GB 2667 MHz DDR4

grahics

Intel UHD Graphics 630 1536 MB
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